Type 1 diabetes incidence in children and adolescents during the COVID-19 pandemic in Germany.

ABSTRACT:

Aims/hypothesis

The aim of this study was to analyze the incidence of type 1 diabetes in children and adolescents (<20 years of age) during the COVID-19 pandemic (3/2020 to 12/2021) in Germany.

Methods

The present study was based on the IQVIA longitudinal prescription database (LRx), All persons (age ≤ 20 years) with new insulin prescriptions from 2016 to 2021 (index date) were selected and stratified by age group. Weekly (age-specific) data were used to forecast the prescription incidence for the pandemic period based on pre-pandemic data and to explore the relationship between weekly reported age-specific COVID-19 incidences and type 1 diabetes incidence and rate ratios of observed vs. predicted diabetes incidence respectively.

Results

During the pre-pandemic period

SUBMITTER: van den Boom L 

PROVIDER: S-EPMC9637016 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature